Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 59.1
0.323 %
$ 10.7 B
Market Cap
-25.92
P/E
CASH FLOW STATEMENT
268 M
OPERATING CASH FLOW
-327 M
INVESTING CASH FLOW
74 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Catalent, Inc.
| Net Income | -1.04 B |
| Depreciation & Amortization | 489 M |
| Capital Expenditures | -327 M |
| Stock-Based Compensation | 68 M |
| Change in Working Capital | -62 M |
| Others | 678 M |
| Free Cash Flow | -59 M |
Cash Flow
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 | Jun-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||
| Net Income | (1 043.0) | (256.0) | 519.0 | 585.0 | 220.7 | 137.4 | 83.6 | 109.8 | 111.2 | 210.2 | 17.9 | (48.0) | 18.1 | (29.1) |
| Depreciation & Amortization | 489.0 | 422.0 | 378.0 | 289.0 | 253.7 | 228.6 | 190.1 | 146.5 | 140.6 | 140.8 | 142.9 | 152.2 | 129.7 | 115.5 |
| Deferred Income Tax | (28.0) | (127.0) | 14.0 | 64.0 | 2.4 | (15.1) | 35.4 | (1.3) | (15.3) | (120.7) | (15.1) | 5.4 | (18.8) | 6.5 |
| Stock Based Compensation | 68.0 | 35.0 | 54.0 | 51.0 | 48.0 | 33.3 | 27.2 | 20.9 | 10.8 | 9.0 | 4.5 | 2.8 | 3.7 | 3.9 |
| Other Operating Activities | 844.0 | 347.0 | 86.0 | (124.0) | 36.7 | 23.8 | 29.4 | 35.4 | 9.7 | 20.8 | 15.2 | 50.6 | 9.2 | 24.4 |
| Change in Working Capital | (62.0) | (160.0) | (612.0) | (432.0) | (121.3) | (160.3) | 8.8 | (11.8) | (101.7) | (88.3) | 12.9 | (25.3) | (54.0) | (21.5) |
| Cash From Operations | 268.0 | 261.0 | 439.0 | 433.0 | 440.3 | 247.7 | 374.5 | 299.5 | 155.3 | 171.8 | 178.3 | 137.7 | 87.9 | 99.7 |
| INVESTING CASH FLOW | ||||||||||||||
| Capital Expenditures | (327.0) | (583.0) | (660.0) | (686.0) | (465.8) | (218.1) | (176.5) | (139.8) | (139.6) | (141.0) | (122.4) | (122.5) | (104.2) | (87.3) |
| Other Items | 0 | (379.0) | (1 224.0) | 37.0 | (361.7) | (1 292.3) | (742.8) | (169.2) | 1.9 | (130.8) | (48.8) | 0.4 | (390.3) | 36.9 |
| Cash From Investing Activities | (327.0) | (962.0) | (1 884.0) | (649.0) | (827.5) | (1 510.4) | (919.3) | (309.0) | (137.7) | (271.8) | (171.2) | (122.1) | (494.5) | (50.4) |
| FINANCING CASH FLOW | ||||||||||||||
| Common Stock Repurchased | 0 | 0 | (10.0) | 0 | 0 | 0 | 0 | (5.4) | (8.7) | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 84.0 | 485.0 | 1 022.0 | 99.0 | 23.2 | 124.2 | 439.5 | 166.7 | (16.3) | (742.0) | (42.3) | (50.5) | 390.4 | (27.4) |
| Dividends Paid | 0 | 0 | (4.0) | (22.0) | (36.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (19.0) | 36.0 | 13.0 | (17.0) | (31.3) | 632.2 | (48.2) | (5.4) | (14.5) | (10.3) | 0 | 0 | (38.6) | (2.6) |
| Cash From Financing Activities | 74.0 | 521.0 | 1 031.0 | 142.0 | 1 001.7 | 1 201.4 | 669.1 | 161.3 | (30.8) | 196.5 | (42.1) | (49.3) | 352.9 | (26.1) |
| CHANGE IN CASH | ||||||||||||||
| Net Change In Cash | 9.0 | (169.0) | (447.0) | (57.0) | 607.8 | (64.8) | 121.9 | 156.7 | (19.7) | 76.9 | (32.0) | (32.6) | (66.1) | 41.1 |
| FREE CASH FLOW | ||||||||||||||
| Free Cash Flow | (59.0) | (322.0) | (221.0) | (253.0) | (25.5) | 29.6 | 198.0 | 159.7 | 15.7 | 30.8 | 55.9 | 15.2 | (16.3) | 12.4 |